Advertisement

Organisation › Details
Euronext (Group)
Euronext is the leading pan-European exchange in the Eurozone with nearly 1,300 listed issuers worth close to €3.6 trillion in market capitalisation as of end December 2017, an unmatched blue chip franchise consisting of 24 issuers in the Morningstar® Eurozone 50 Index? and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets. Its total product offering includes Equities, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, Euronext also operates Euronext GrowthTM (formerly known as Alternext) and Euronext AccessTM (formerly known as the Free Market). *
![]() |
Industry | financial services |
![]() |
Person | Boujnah, Stéphane (Euronext 201711 CEO) |
![]() |
Region | Amsterdam |
Country | Netherlands | |
Street | 5 Beursplein | |
City | n. a. Amsterdam | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 532,300,000 (revenue, consolidated (2017) 2017-12-31) | |
Profit | 241,300,000 (2017-12-31) | |
Cash | 187,800,000 (2017-12-31) | |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement

More documents for Euronext (Group)
- [1] BenevolentAI Ltd.. (12/11/24). "Press Release: BenevolentAI Unveils Major Strategic Overhaul with Return to Original Mission". London....
- [2] TME Pharma N.V.. (12/4/24). "Press Release: (CORRECTING and REPLACING) TME Pharma Announces Corporate Strategy Update and Upcoming €2.6 Million Guaranteed Financing With Intention to Launch Public Offer Open Only to Shareholders to Enable Completion of ...
- [3] Carbios S.A.. (7/11/23). "Press Release: Carbios Announces the Success of Its Capital Increase with Preferential Subscription Rights of Approximately 141 Million Euros, the Largest on Euronext Growth since 2015". Clermont-Ferrand....
- [4] Carbios S.A.. (6/22/23). "Press Release: Carbios Announces the Launch of a Rights Issue Totalling around €122 Million, Likely to Be Increased to around €141 Million if the Extension Clause Is Fully Exercised". Clermont-Ferrand....
- [5] BenevolentAI. (4/25/22). "Press Release: BenevolentAI Begins Trading On Euronext Amsterdam". London....
- [6] Euronext N.V.. (4/25/22). "Press Release: BenevolentAI Lists on Euronext Amsterdam. Listed Following Business Combination with Odyssey Acquisition S.A.". Amsterdam....
- [7] Aelis Farma S.A.. (2/15/22). "Press Release: Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Announces the Success of Its Initial Public Offering and Raises approximately €25 Million on Euronext Paris [N...
- [8] Euronext N.V.. (11/18/21). "Press Release: European Healthcare Acquisition & Growth Company B.V (EHC) Lists on Euronext Amsterdam". Amsterdam....
- [9] Euronext N.V.. (11/2/21). "Press Release: Acticor Biotech Lists on Euronext Growth Paris". Paris....
- [10] MaaT Pharma. (10/15/21). "Press Release: MaaT Pharma Launches Its Initial Public Offering on the Regulated Market of Euronext in Paris [ Not for US, CA, AU, JP or RK ]". Lyon....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top